Global Drug-Coated Balloon for Peripheral Artery Diseases Market Research Report 2025(Status and Outlook)

March 2025 | 205 pages | ID: GE3A935116DAEN
Bosson Research

Abstracts

Report Overview

Drug-coated balloons (DCB), also referred to as drug-eluting balloons (DEB), were created as a way to reduce very high restenosis rates in peripheral vessels.

This report provides a deep insight into the global Drug-Coated Balloon for Peripheral Artery Diseases market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug-Coated Balloon for Peripheral Artery Diseases Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug-Coated Balloon for Peripheral Artery Diseases market in any manner.

Global Drug-Coated Balloon for Peripheral Artery Diseases Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Medtronic

Boston Scientific

BD

Philips

Aachen Resonance

Market Segmentation (by Type)

Paclitaxel Coated

Other Coated

Market Segmentation (by Application)

Hospitals

ASCs

Catheterization Laboratory

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Drug-Coated Balloon for Peripheral Artery Diseases Market
• Overview of the regional outlook of the Drug-Coated Balloon for Peripheral Artery Diseases Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug-Coated Balloon for Peripheral Artery Diseases Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Drug-Coated Balloon for Peripheral Artery Diseases
1.2 Key Market Segments
1.2.1 Drug-Coated Balloon for Peripheral Artery Diseases Segment by Type
1.2.2 Drug-Coated Balloon for Peripheral Artery Diseases Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Overview
2.1 Global Market Overview
2.1.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Product Life Cycle
3.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Manufacturers (2020-2025)
3.4 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Manufacturers (2020-2025)
3.5 Drug-Coated Balloon for Peripheral Artery Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Drug-Coated Balloon for Peripheral Artery Diseases Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Drug-Coated Balloon for Peripheral Artery Diseases Manufacturing Sites, Area Served, Product Type
3.8 Drug-Coated Balloon for Peripheral Artery Diseases Market Competitive Situation and Trends
3.8.1 Drug-Coated Balloon for Peripheral Artery Diseases Market Concentration Rate
3.8.2 Global 5 and 10 Largest Drug-Coated Balloon for Peripheral Artery Diseases Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Drug-Coated Balloon for Peripheral Artery Diseases Industry Chain Analysis
4.1 Drug-Coated Balloon for Peripheral Artery Diseases Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Drug-Coated Balloon for Peripheral Artery Diseases Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Drug-Coated Balloon for Peripheral Artery Diseases Market
5.7 ESG Ratings of Leading Companies
6 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Sales by Region
6.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region
6.1.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region
6.1.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Region
6.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Region
6.2.1 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Region
6.2.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size Market Share by Region
7 North America Market Overview
7.1 North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type
7.3 North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application
8 Europe Market Overview
8.1 Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type
8.3 Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type
9.3 Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application
10 South America Market Overview
10.1 South America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type
10.3 South America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type
11.3 Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application
12 Drug-Coated Balloon for Peripheral Artery Diseases Market Production by Region
12.1 Global Production of Drug-Coated Balloon for Peripheral Artery Diseases by Region(2020-2025)
12.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Region (2020-2025)
12.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Drug-Coated Balloon for Peripheral Artery Diseases Production
12.4.1 North America Drug-Coated Balloon for Peripheral Artery Diseases Production Growth Rate (2020-2025)
12.4.2 North America Drug-Coated Balloon for Peripheral Artery Diseases Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Drug-Coated Balloon for Peripheral Artery Diseases Production
12.5.1 Europe Drug-Coated Balloon for Peripheral Artery Diseases Production Growth Rate (2020-2025)
12.5.2 Europe Drug-Coated Balloon for Peripheral Artery Diseases Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Drug-Coated Balloon for Peripheral Artery Diseases Production (2020-2025)
12.6.1 Japan Drug-Coated Balloon for Peripheral Artery Diseases Production Growth Rate (2020-2025)
12.6.2 Japan Drug-Coated Balloon for Peripheral Artery Diseases Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Drug-Coated Balloon for Peripheral Artery Diseases Production (2020-2025)
12.7.1 China Drug-Coated Balloon for Peripheral Artery Diseases Production Growth Rate (2020-2025)
12.7.2 China Drug-Coated Balloon for Peripheral Artery Diseases Production, Revenue, Price and Gross Margin (2020-2025)
13 Drug-Coated Balloon for Peripheral Artery Diseases Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2020-2033)
13.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size Market Share by Type (2020-2033)
13.4 Global Drug-Coated Balloon for Peripheral Artery Diseases Price by Type (2020-2033)
14 Drug-Coated Balloon for Peripheral Artery Diseases Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Sales by Application (2020-2033)
14.3 Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Application (2020-2033)
14.4 Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Medtronic
15.1.1 Medtronic Basic Information
15.1.2 Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Product Overview
15.1.3 Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Product Market Performance
15.1.4 Medtronic Business Overview
15.1.5 Medtronic SWOT Analysis
15.1.6 Medtronic Recent Developments
15.2 Boston Scientific
15.2.1 Boston Scientific Basic Information
15.2.2 Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Product Overview
15.2.3 Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Product Market Performance
15.2.4 Boston Scientific Business Overview
15.2.5 Boston Scientific SWOT Analysis
15.2.6 Boston Scientific Recent Developments
15.3 BD
15.3.1 BD Basic Information
15.3.2 BD Drug-Coated Balloon for Peripheral Artery Diseases Product Overview
15.3.3 BD Drug-Coated Balloon for Peripheral Artery Diseases Product Market Performance
15.3.4 BD Business Overview
15.3.5 BD SWOT Analysis
15.3.6 BD Recent Developments
15.4 Philips
15.4.1 Philips Basic Information
15.4.2 Philips Drug-Coated Balloon for Peripheral Artery Diseases Product Overview
15.4.3 Philips Drug-Coated Balloon for Peripheral Artery Diseases Product Market Performance
15.4.4 Philips Business Overview
15.4.5 Philips Recent Developments
15.5 Aachen Resonance
15.5.1 Aachen Resonance Basic Information
15.5.2 Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Product Overview
15.5.3 Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Product Market Performance
15.5.4 Aachen Resonance Business Overview
15.5.5 Aachen Resonance Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug-Coated Balloon for Peripheral Artery Diseases Market Size Comparison by Region (M USD)
Table 5. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Coated Balloon for Peripheral Artery Diseases as of 2024)
Table 10. Global Market Drug-Coated Balloon for Peripheral Artery Diseases Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Drug-Coated Balloon for Peripheral Artery Diseases Manufacturing Sites and Area Served
Table 12. Manufacturers Drug-Coated Balloon for Peripheral Artery Diseases Product Type
Table 13. Global Drug-Coated Balloon for Peripheral Artery Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Drug-Coated Balloon for Peripheral Artery Diseases Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Region (2020-2025) & (K Units)
Table 25. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Region (2020-2025)
Table 26. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Region (2020-2025) & (M USD)
Table 27. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size Market Share by Region (2020-2025)
Table 28. North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country (2020-2033) & (M USD)
Table 29. North America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2020-2033) & (K Units)
Table 30. North America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (K Units)
Table 31. North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type (M USD)
Table 32. North America Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Type (2020-2033)
Table 33. North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Type (2020-2033)
Table 34. North America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (K Units)
Table 35. North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application (M USD)
Table 36. North America Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Application (2020-2033)
Table 37. North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Application (2020-2033)
Table 38. Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country (2020-2033) & (M USD)
Table 39. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2020-2033) & (K Units)
Table 40. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (K Units)
Table 41. Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type (M USD)
Table 42. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Type (2020-2033)
Table 43. Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Type (2020-2033)
Table 44. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (K Units)
Table 45. Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application (M USD)
Table 46. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Application (2020-2033)
Table 47. Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Application (2020-2033)
Table 48. Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country (2020-2025) & (M USD)
Table 49. Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2020-2025) & (K Units)
Table 50. Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (K Units)
Table 51. Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type (M USD)
Table 52. Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Type (2020-2033)
Table 53. Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Type (2020-2025)
Table 54. Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (K Units)
Table 55. Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application (M USD)
Table 56. Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Application (2020-2033)
Table 57. Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Application (2020-2025)
Table 58. South America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country (2020-2033) & (M USD)
Table 59. South America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2020-2033) & (K Units)
Table 60. South America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (K Units)
Table 61. South America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type (M USD)
Table 62. South America Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Type (2020-2033)
Table 63. South America Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Type (2020-2033)
Table 64. South America Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (K Units)
Table 65. South America Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application (M USD)
Table 66. South America Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Application (2020-2033)
Table 67. South America Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Application (2020-2033)
Table 68. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country (2020-2033) & (M USD)
Table 69. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Country (2020-2033) & (K Units)
Table 70. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (K Units)
Table 71. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type (M USD)
Table 72. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Type (2020-2033)
Table 73. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Type (2020-2033)
Table 74. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (K Units)
Table 75. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application (M USD)
Table 76. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Application (2020-2033)
Table 77. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Application (2020-2033)
Table 78. Global Drug-Coated Balloon for Peripheral Artery Diseases Production (K Units) by Region(2020-2025)
Table 79. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue (US$ Million) by Region (2020-2025)
Table 80. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Market Share by Region (2020-2025)
Table 81. Global Drug-Coated Balloon for Peripheral Artery Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. North America Drug-Coated Balloon for Peripheral Artery Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Europe Drug-Coated Balloon for Peripheral Artery Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Japan Drug-Coated Balloon for Peripheral Artery Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. China Drug-Coated Balloon for Peripheral Artery Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Type (K Units)
Table 87. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type (M USD)
Table 88. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Type (2020-2033)
Table 89. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Type (2020-2033)
Table 90. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Type (2020-2033)
Table 91. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size Share by Type (2020-2033)
Table 92. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) by Application
Table 93. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application(M USD)
Table 94. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales by Application (2020-2033) & (K Units)
Table 95. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2020-2033)
Table 96. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application (2020-2033) & (M USD)
Table 97. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Share by Application (2020-2033)
Table 98. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Growth Rate by Application (2020-2033)
Table 99. Medtronic Basic Information
Table 100. Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Product Overview
Table 101. Medtronic Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Medtronic Business Overview
Table 103. Medtronic SWOT Analysis
Table 104. Medtronic Recent Developments
Table 105. Boston Scientific Basic Information
Table 106. Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Product Overview
Table 107. Boston Scientific Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Boston Scientific Business Overview
Table 109. Boston Scientific SWOT Analysis
Table 110. Boston Scientific Recent Developments
Table 111. BD Basic Information
Table 112. BD Drug-Coated Balloon for Peripheral Artery Diseases Product Overview
Table 113. BD Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. BD Business Overview
Table 115. BD SWOT Analysis
Table 116. BD Recent Developments
Table 117. Philips Basic Information
Table 118. Philips Drug-Coated Balloon for Peripheral Artery Diseases Product Overview
Table 119. Philips Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Philips Business Overview
Table 121. Philips Recent Developments
Table 122. Aachen Resonance Basic Information
Table 123. Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Product Overview
Table 124. Aachen Resonance Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Aachen Resonance Business Overview
Table 126. Aachen Resonance Recent Developments
List of Figures
Figure 1. Product Picture of Drug-Coated Balloon for Peripheral Artery Diseases
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD), 2024-2033
Figure 5. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) (2020-2033)
Figure 6. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Drug-Coated Balloon for Peripheral Artery Diseases Product Life Cycle
Figure 13. Drug-Coated Balloon for Peripheral Artery Diseases Sales Share by Manufacturers in 2024
Figure 14. Global Drug-Coated Balloon for Peripheral Artery Diseases Revenue Share by Manufacturers in 2024
Figure 15. Drug-Coated Balloon for Peripheral Artery Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Drug-Coated Balloon for Peripheral Artery Diseases Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Drug-Coated Balloon for Peripheral Artery Diseases Revenue in 2024
Figure 18. Industry Chain Map of Drug-Coated Balloon for Peripheral Artery Diseases
Figure 19. Global Drug-Coated Balloon for Peripheral Artery Diseases Market PEST Analysis
Figure 20. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Region (2020-2025)
Figure 26. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size Market Share by Region (2020-2025)
Figure 27. North American Market Snapshot
Figure 28. North America Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 29. North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 30. North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Country
Figure 31. USA Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 32. USA Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 33. Canada Drug-Coated Balloon for Peripheral Artery Diseases Sales (K Units) and Growth Rate (2020-2033)
Figure 34. Canada Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) and Growth Rate (2020-2033)
Figure 35. Mexico Drug-Coated Balloon for Peripheral Artery Diseases Sales (Units) and Growth Rate (2020-2033)
Figure 36. Mexico Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD)by Type
Figure 38. North America Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Application
Figure 39. Europe Market Snapshot
Figure 40. Europe Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 41. Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 42. Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Country
Figure 43. Germany Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 44. Germany Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 45. France Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. France Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. U.K. Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. U.K. Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 49. Italy Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. Italy Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 51. Spain Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Spain Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Type
Figure 54. Europe Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Application
Figure 55. Asia-Pacific Market Snapshot
Figure 56. Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 57. Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Country
Figure 59. China Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. China Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Japan Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Japan Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. South Korea Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. South Korea Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. India Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. India Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. Southeast Asia Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. Southeast Asia Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Type
Figure 70. Asia-Pacific Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Application
Figure 71. South America Market Snapshot
Figure 72. South America Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 73. South America Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 74. South America Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Country
Figure 75. Brazil Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 76. Brazil Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 77. Argentina Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Argentina Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Columbia Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Columbia Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. South America Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Type
Figure 82. South America Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Application
Figure 83. Middle East and Africa Market Snapshot
Figure 84. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 85. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 86. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Country
Figure 87. Saudi Arabia Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 88. Saudi Arabia Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 89. UAE Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. UAE Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. Egypt Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. Egypt Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Nigeria Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Nigeria Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. South Africa Drug-Coated Balloon for Peripheral Artery Diseases Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. South Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Type
Figure 98. Middle East and Africa Drug-Coated Balloon for Peripheral Artery Diseases Market Size (M USD) by Application
Figure 99. Global Drug-Coated Balloon for Peripheral Artery Diseases Production Market Share by Region (2020-2025)
Figure 100. North America Drug-Coated Balloon for Peripheral Artery Diseases Production (K Units) Growth Rate (2020-2025)
Figure 101. Europe Drug-Coated Balloon for Peripheral Artery Diseases Production (K Units) Growth Rate (2020-2025)
Figure 102. Japan Drug-Coated Balloon for Peripheral Artery Diseases Production (K Units) Growth Rate (2020-2025)
Figure 103. China Drug-Coated Balloon for Peripheral Artery Diseases Production (K Units) Growth Rate (2020-2025)
Figure 104. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 105. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Type (M USD)
Figure 106. Sales Market Share of Drug-Coated Balloon for Peripheral Artery Diseases by Type (2020-2033)
Figure 107. Sales Market Share of Drug-Coated Balloon for Peripheral Artery Diseases by Type in 2024
Figure 108. Market Size Share of Drug-Coated Balloon for Peripheral Artery Diseases by Type (2020-2033)
Figure 109. Market Size Share of Drug-Coated Balloon for Peripheral Artery Diseases by Type in 2024
Figure 110. Global Drug-Coated Balloon for Peripheral Artery Diseases Price (USD/Unit) by Type (2020-2033)
Figure 111. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 112. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Size by Application(M USD)
Figure 113. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Share by Application
Figure 114. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application (2020-2033)
Figure 115. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Market Share by Application in 2024
Figure 116. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Share by Application (2020-2033)
Figure 117. Global Drug-Coated Balloon for Peripheral Artery Diseases Market Share by Application in 2024
Figure 118. Global Drug-Coated Balloon for Peripheral Artery Diseases Sales Growth Rate by Application (2020-2033)